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a  b  s  t  r  a  c  t
A  potentially  useful  means  of  predicting  the  pulmonary  risk  posed  by  new  forms  of nano-structured
titanium  dioxide  (nano-TiO2)  is  to use the  associations  between  the physicochemical  properties  and
pulmonary  toxicity  of  characterized  forms  of TiO2. In  the  present  study,  we conducted  intratracheal
administration  studies  in  rats  to clarify  the  associations  between  the  physicochemical  characteristics  of
seven  characterized  forms  of  TiO2 and  their  acute  or subacute  pulmonary  inﬂammatory  toxicity.  Exam-
ination  of  the  associations  between  the physicochemical  characteristics  of  the TiO2 and  the  pulmonary
inﬂammatory  responses  they  induced  revealed  (1)  that  differences  in  the  crystallinity  or shape  of  the
TiO2 particles  were  not  associated  with  the  acute  pulmonary  inﬂammatory  response;  (2) that  particle
size  was  associated  with  the  acute  pulmonary  inﬂammatory  response;  and  (3)  that  TiO2 particles  coated
with  Al(OH)3 induced  a greater  pulmonary  inﬂammatory  response  than  did non-coated  particles.  We
separated  the  seven  TiO2 into  two groups:  a  group  containing  the  six TiO2 with  no  surface  coating  and  a
group  containing  the  one  TiO2 with  a surface  coating.  Intratracheal  administration  to  rats  of  TiO2 from  the
ﬁrst  group  (i.e.,  non-coated  TiO2) induced  only  acute  pulmonary  inﬂammatory  responses,  and  within  this
group,  the  acute  pulmonary  inﬂammatory  response  was  equivalent  when  the  particle  size  was  the  same,
regardless  of crystallinity  or shape.  In contrast,  intratracheal  administration  to rats  of  the  TiO2 from  the
second group  (i.e.,  the  coated  TiO2)  induced  a more  severe,  subacute  pulmonary  inﬂammatory  response
compared  with  that produced  by  the non-coated  TiO2. Since  alteration  of the  pulmonary  inﬂammatory
response  by surface  treatment  may  depend  on  the coating  material  used,  the  pulmonary  toxicities  of
coated  TiO2 need  to be further  evaluated.  Overall,  the  present  results  demonstrate  that physicochemical
properties  may  be  useful  for  predicting  the pulmonary  risk  posed  by new  nano-TiO2 materials.
©  2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the  CC  BY. Introduction
The European Commission deﬁnes a nanomaterial as “a natu-
al, incidental or manufactured material containing particles, in an
nbound state or as an aggregate or as an agglomerate and where,
or 50% or more of the particles in the number size distribution,
ne or more external dimensions is in the size range 1 nm–100 nm”
∗ Corresponding author.
E-mail address: hashizume-naoki@ceri.jp (N. Hashizume).
1 The ﬁrst three authors equally contributed to the manuscript.
ttp://dx.doi.org/10.1016/j.toxrep.2016.05.005
214-7500/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access license  (http://creativecommons.org/licenses/by/4.0/).
[1]. Due to this small particle size, the surface area per unit mass
of nanomaterials is greater than that of the corresponding bulk
materials, and it is this characteristic that gives nanomaterials their
unique properties.
Nanomaterials are predicted to soon become the cornerstone
of the microelectronics, materials, textiles, energy, healthcare, and
cosmetics industries [2]. Indeed, nano-structured titanium dioxide
(nano-TiO2) is one of the most widely used nanomaterials in the
world, and the production volume of nano-TiO2, which is increas-
ing annually, is expected to reach nearly 2.5 million metric tons per
year in 2025 [3]. Traditionally, TiO2 ﬁne particles have been con-
sidered to have low toxicity; however, concerns have been raised
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ecently regarding the potential health risks posed by nano-TiO2
o consumers, workers, and the environment [4]. In particular,
 recently published toxicological review showed that inhalation
as the primary route of nano-TiO2 exposure and thus highlighted
he need for more information on the safety of nano-TiO2 [5].
any researchers and regulators are now trying to understand
he hazards of nano-TiO2 and determine appropriate strategies for
he assessment of the pulmonary risk associated with exposure
o nano-TiO2 materials. Nano-TiO2 can be manufactured in vari-
us forms that have different physicochemical characteristics (e.g.,
rystallinity, shape, particle size, surface area, and surface modiﬁ-
ation), which can lead to nanomaterials with the same chemical
ormula but different pulmonary toxicities [6]. Therefore, from a
egulatory standpoint, it would be beneﬁcial to assess the pul-
onary risk of all newly developed nano-TiO2 materials; however,
 program of this size is unrealistic due to the time and money that
ould be required.
One potential means of predicting the pulmonary risk of new
orms of nano-TiO2 is to use the associations between the physic-
chemical properties and pulmonary toxicity of characterized
orms of TiO2. Several researchers have already investigated the
elationships between the physicochemical characteristics of dif-
erent forms of nano-TiO2 and their pulmonary toxicities in rats,
ncluding the relationship between pulmonary toxicity and parti-
le crystallinity [7], particle size [8,9,10,11,12], particle surface area
13,10,12], and particle surface modiﬁcation [14,15,16]. For exam-
le, smaller TiO2 particles have been shown to induce a greater
cute inﬂammatory response compared with larger TiO2 parti-
les after intratracheal administration in rats [8,9,11]. However,
arheit et al. [12] have also shown that the acute inﬂammatory
nd cell-injury effects of three TiO2 materials with different particle
izes did not differ. Furthermore, in most of these previous stud-
es only two or three test materials were examined and the studies
ere conducted under different test conditions, thus hampering
omparison of the results.
In the present study, to clarify the associations between the
hysicochemical characteristics of TiO2-based materials and their
ulmonary toxicity, intratracheal administration studies were con-
ucted in rats by using seven different characterized TiO2. To allow
 quantitative and statistical approach to be used, all physicochem-
cal characterizations and in vivo studies were performed in the
ame laboratory under the same test conditions.
. Materials and methods
.1. Test materials and preparation of administration
ormulations
Seven forms of TiO2 were selected for inclusion in this study:
MT-100, MT-150AW, and MP-100 (Tayca Co. Ltd., Japan); TTO-
-3, TTO-S-3 (Coated), and FTL-100 (Ishihara Sangyo Kaisha, LTD.,
apan); and P25 (Evonik Industries, Germany). These materials
ere chosen to allow examination of as many different physic-
chemical characteristics as possible, i.e., three different types
f crystallinity, three different particle shapes, surface coating
untreated or Al[OH]3 coating), and a range of different parti-
le sizes (Table 1). Representative scanning electron microscope
mages (S-4800, Hitachi High-Technologies Co., Japan) of each test
aterial are shown in Fig. S1.
Administration formulations were prepared as described in
efs. [17,18] (Table S1). Brieﬂy, 2 g of test material was  dispersed
n 50 mL  of 2 mg/mL  of disodium phosphate (food additive grade;
ako Pure Chemical Industries, Ltd., Japan), which was  prepared
y using endotoxin-free pure water. The suspension was sonicated
n a glass bottle by using an ultrasonic bath (5510J-MT; BransonReports 3 (2016) 490–500 491
Ultrasonics Co., USA) for one to three hours and then centrifuged
at 20–1000g for 5–40 min  at 20 ◦C (CF16RXII and T15A41; Hitachi
Koki Co., Ltd., Japan). The supernatant was  collected as a stock
suspension. Administration formulations were prepared by dilut-
ing the stock suspension to the appropriate concentration with
2 mg/mL  disodium phosphate. The concentration of test material in
the administration formulations was  determined by using a weight
analysis method, where the weight loss of the suspension was mea-
sured with a balance scale (AUW220D; Shimadzu Co., Japan) after
drying at 200 ◦C in a thermostatic chamber (ON-300S; As One Co.,
Japan). The particle size and size distribution of the test materi-
als in the administration formulations were measured by means
of dynamic light scattering (Zetasizer Nano ZS; Malvern Instru-
ments Ltd., UK). In principle, particle size and size distribution
can be expressed in terms of mass, volume, or number of parti-
cles [19]. However, since a robust understanding of which means
of expression is the best for understanding the pulmonary toxicity
of TiO2 in rats is yet to be obtained, two different values—volume
average diameter and number average diameter—obtained from
the dynamic light scattering analysis were used in the present
study (Table 1 and Fig. S2). The particle size of FTL-100 was not
determined because dynamic light scattering gives little effective
information for needle-shaped particles with a large aspect ratio.
2.2. Test animals
Male F344/DuCrlCrlj rats were obtained from Charles River Lab-
oratories Japan, Inc. Animals at 12 weeks of age with body weights
of 212.3–282.1 g on the day of administration were used in the
in vivo studies. The animals were housed in animal rooms equipped
with a local barrier system and were maintained at 21–25 ◦C and
40% to 70% relative humidity with 10–15 air changes per hour and
a photoperiod of 12 h of light per day (lights on, 7:00; lights off,
19:00). The study was approved by the Institutional Animal Care
and Use Committee prior to the start of the study.
2.3. Test conditions
In the in vivo studies, one vehicle control group (2 mg/mL of
disodium phosphate aqueous solution without test material) and
three treatment groups (0.67, 2, or 6 mg/kg TiO2) were used for
each test material. The majority of previous studies using intratra-
cheal administration of TiO2 in rats were conducted with doses in
the range of 0.75–6 mg/kg TiO2 [8,9,20,11,12,7]. Therefore, based
on the results of these previous studies, the doses in the present
study were chosen so that toxic effects but not death or severe
suffering were induced at the highest dose and so that adverse
effects were avoided at the lowest dose. Forty rats were used
for each test material (i.e., ten test animals/dose). Test animals
were anesthetized by means of isoﬂurane inhalation and angled
approximately 45◦ on a restraining stand. Administrations were
conducted by using a stomach sonde (Natsume Seisakusho Co., Ltd.,
Japan) or MicroSprayer Aerosolizer (Model IA-1B-R for Rat, Penn-
Century, Inc., USA) inserted transorally into the tracheal lumen at
a depth of approximately 6 cm from the angle of the mouth. The
volumes of the administrations were 1 mL/kg for AMT-100, MT-
150AW, TTO-S-3, TTO-S-3 (Coated), P25 and MP-100, and 2 mL/kg
for FTL-100, based on the animal’s body weight on the day of admin-
istration. To assess the acute and subacute pulmonary toxicity of
each test material, bronchoalveolar lavage ﬂuid (BALF) examina-
tion and pathological examination were conducted at three days
(acute phase) and at four weeks (subacute phase) after intratracheal
administration. The examinations were not conducted earlier than
three days after administration because the results would likely
reﬂect the initial pulmonary inﬂammatory response to the bolus
administration of liquid into the lungs [8]. On the day of exam-
492 N. Hashizume et al. / Toxicology Reports 3 (2016) 490–500
Table 1
Physicochemical characteristics of the seven forms of TiO2.
Material Crystallinitya Shapea Primary particle
sizea(nm)
Surface area(m2/g) Surface coatinga Particle sizeb(nm)
Volume average
diameter
Number average
diameter
AMT-100 anatase spherical 6 250–300 No 185(161–198) 68.5(60.6–82.6)
MT-150AW rutile spindle long axis:28.8
short axis:7.6
100–120 No 58.5(52.3–65.8) 28.7(19.5–42.6)
TTO-S-3 rutile spindle long axis:50–100
short axis:10–20
102 No 61.9(57.2–64.7) 45.8(41.2–48.9)
TTO-S-3 (Coated) rutile spindle long axis:50–100
short axis:10–20
93.0 Al(OH)3 coating 241(202–289) 125(119–133)
P25  rutile/anatase
(20/80)
spherical 21 50 ± 15 No 99.2(95.6–101) 73.8(65.5–79.8)
MP-100 rutile spherical 1000 6 No 531(501–549) 289(89.8–393)
FTL-100 rutile needle long axis:1680
short axis:130
12.0 No −c −c
a Data from catalog or obtained from the manufacturer.
b Average particle diameter was measured in the three different administration formulations by means of dynamic light scattering (Zetasizer Nano ZS; Malvern Instruments
Ltd.,  UK). Figures in parentheses show the smallest to largest value among the three different concentrations. Intensity size distributions measured by dynamic light scattering
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c Particle size was  not calculated because dynamic light scattering gives little eff
nation, ten test animals per dose were euthanized by means of
leeding via the ventral aorta under pentobarbital anesthesia. Five
nimals were used for the BALF examination, and ﬁve animals were
sed for the pathological examination. Test animals were fasted for
6–20 h prior to euthanasia and dissection. In all animals, clinical
igns were observed daily after intratracheal administration, and
ody weight was recorded before the administration of the test
aterials, at three and seven days after administration, and once
er week thereafter until the end of the study.
.4. BALF examination
The trachea of each rat was cannulated and 7 mL  of saline
Otsuka Pharmaceutical Co., Ltd, Japan) was instilled into the lungs
y means of gravity; that is, saline was instilled into the lungs from
0 cm above the test animal and then drained from the lungs to
 bottle that was placed 30 cm under the test animal. The lavage
rocedure was conducted twice (i.e., a total of 14 mL  of saline
as instilled into the lungs). Approximately 90% of the instilled
aline volume was retrieved. Total cell counts were determined
n a portion of the BALF by using an ADVIA 120 hematology ana-
yzer (Siemens Healthcare Diagnostics, USA). The remaining BALF
as centrifuged (400g, 10 min, 4 ◦C), and the total protein content,
oncentrations of albumin, lactate dehydrogenase (LDH) activity,
nd alkaline phosphatase (ALP) activity in the supernatant were
etermined by using a Hitachi Automatic Clinical Analyzer 7170
Hitachi High-Technologies Corporation Co., Japan). The cell pel-
ets were re-suspended in phosphate-buffered saline and smeared
nto glass slides; 200 cells per specimen were counted to determine
he leukocyte differential (neutrophils, macrophages, lymphocytes,
asophils, and eosinophils).
.5. Pathological examinations
The lungs, trachea, parathymic lymph nodes, posterior medi-
stinal lymph node, liver, kidneys, spleen, and brain were removed
rom the rats. The weights of the lungs, liver, kidneys, spleen,
nd brain were measured to calculate relative organ weights
er body weight (g/100 g). The organs were ﬁxed with 10%
v/v) neutral phosphate-buffered formalin solution, stained with
ematoxylin–eosin, and examined histopathologically under a
ight microscope. information for needle-shaped particles with a large aspect ratio.
2.6. Associations between the physicochemical characteristics of
TiO2 and the pulmonary inﬂammatory response in rats
To investigate the associations between the physicochemical
characteristics of the TiO2 (i.e., crystallinity, shape, particle size,
and surface coating) and the pulmonary inﬂammatory response
to the TiO2 in rats (i.e., acute or subacute), we used three
BALF parameters—differential neutrophil ratio (an indicator of
inﬂammatory response), total protein content (an indicator of per-
meability of vessels to protein in blood), and LDH activity (an
indicator of cell injury). These BALF parameters have previously
been used to evaluate the pulmonary toxicity of nano-TiO2 in
rats [14,8,21,22,11,16,12,7]. When analysing the dose-dependency
of the three BALF parameters, we  suspected that at three days
after intratracheal administration of the TiO2, some of the param-
eters might be saturated in the rats administered 6 mg/kg TiO2.
Therefore, the values of the BALF parameters obtained for the rats
administered 2 mg/kg TiO2 were used. To standardize the results
obtained for each test material, the results of the BALF examina-
tions are expressed as the difference between the value in the rats
administered 2 mg/kg TiO2 and that in the control rats.
2.7. Statistical analysis
Statistical analyses of body weight, BALF parameters, and rela-
tive organ weight were conducted by using the StatLight software
(Yukms Co., Ltd., Japan). Bartlett’s test for homogeneity of variance
was conducted, and when the variances were homogeneous at a
signiﬁcance level of 5%, Dunnett’s test was conducted. When the
variances were not homogeneous, Dunnett’s test for nonparamet-
ric data was  conducted. Statistical signiﬁcances were judged at the
5% probability level. Regression analyses were performed by using
Microsoft Ofﬁce Excel 2013 and GraphPad Prism 6 version 6.01
(GraphPad Software, Inc., USA) for Windows.
3. Results
3.1. Clinical signs and body weightNo mortalities or abnormalities in clinical signs were observed
in either the control or treatment animals for all test materials. The
body weight of all rats increased with increasing age, and there
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Fig. 1. Differential neutrophil ratio in bronchoalveolar lavage ﬂuid at three days (A)
and at four weeks (B) after intratracheal administration of various forms of TiO2.
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Fig. 2. Total protein content in bronchoalveolar lavage ﬂuid at three days (A) andalues are presented as average ± SD. * signiﬁcant difference from control group
P  < 0.05).
ere no signiﬁcant differences in body weight between the control
nd treatment groups for all test materials (data not shown).
.2. BALF examinations
.2.1. Cells in BALF
The results of the BALF examinations at three days and at four
eeks after administration of the test materials are shown in Figs.
 and S3−6. At three days after administration, dose-dependent
ncreases in the differential neutrophil ratio were observed for
ll of the test materials (Fig. 1A). At four weeks after administra-
ion, although signiﬁcant increases in differential neutrophil ratio
emained in the animals administered 6 mg/kg MT-150AW, P25, or
P-100, the increases in differential neutrophil ratio had recovered
o levels comparable with those in the control groups, except for in
he animals administered 2 or 6 mg/kg TTO-S-3 (Coated) (Fig. 1B).
imilar results were observed for total cell count (Fig. S3), differ-
ntial macrophage ratio (Fig. S4), and differential lymphocyte ratio
Fig. S5). No signiﬁcant differences in differential eosinophil ratio
t three days or at four weeks after administration were observed
or any of the test materials (Fig. S6).
.2.2. Biochemical examination of BALF
The results of the biochemical examination of BALF are shown
n Figs. 2, 3, S7, and S8. At three days after administration, dose-
ependent increases in total protein content were observed for
ll of the test materials except MP-100 (Fig. 2A). At four weeks
fter administration, although signiﬁcant increases in total protein
ontent remained in the animals administered 6 mg/kg P25, the
ncreases in total protein content had recovered to levels compara-at  four weeks (B) after intratracheal administration of various forms of TiO2. Values
are presented as average ± SD. * signiﬁcant difference from control group (P < 0.05).
ble with those in the control groups for all test materials, except for
in the rats administered 6 mg/kg TTO-S-3 (Coated) (Fig. 2B). Similar
trends were observed for LDH activity (Fig. 3), albumin concentra-
tion (Fig. S7), and ALP activity (Fig. S8).
3.3. Pathological examinations
3.3.1. Relative organ weight
At three days after administration, signiﬁcant increases in rel-
ative lung weight were observed in the rats administered 6 mg/kg
TiO2, except in those administered MP-100 or FTL-100 (Fig. 4A). For
MT-150AW or TTO-S-3, signiﬁcant increases were also observed in
the animals administered 2 mg/kg. At four weeks after adminis-
tration, signiﬁcant increases in relative lung weight remained in
the animals administered 6 mg/kg MT-150AW, TTO-S-3 (Coated),
or P25 (Fig. 4B). No signiﬁcant differences were observed in the
relative organ weight of liver, kidney, spleen, and brain for any of
the test materials (data not shown).
3.3.2. Histopathological examinations
At three days after administration, inﬂammation in the lung
was observed for all test materials. Inﬁltration of inﬂammatory
cells (neutrophils and alveolar macrophages) or hyperplasia of the
alveolar epithelium with thickening of the alveolar wall, or both,
were observed for all test materials (Table 2 and Fig. 5). Most
of the histopathological changes were very slight with only MT-
150AW and P25 inducing mild changes at the highest dose at
three days after administration. The frequency and grade of the
histopathological changes increased in a dose-dependent manner.
At four weeks after administration, the inﬂammatory responses
had subsided in all groups, except for in the animals administered
494 N. Hashizume et al. / Toxicology Reports 3 (2016) 490–500
Table 2
Comparison of frequency and grade of histopathological responses.
Test material
AMT-100 MT-150AW TTO-S-3 TTO-S-3 (Coated) P25 MP-100 FTL-100
Administration dose (mg/kg)
0.67 2 6 0.67 2 6 0.67 2 6 0.67 2 6 0.67 2 6 0.67 2 6 0.67 2 6
(At  three days after administration)
Inﬁltration of inﬂammatory cells (neutrophils and alveolar macrophages)
± 1 1 3 0 2 0 1 2 0 0 1 2 0 0 1 1 0 1 1 0 3
+  0 0 1 0 3 5 0 2 5 0 0 3 0 0 4 0 0 0 0 0 1
Hyperplasia of alveolar epithelium
± 0 1 0 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 2
+  0 0 0 0 0 0 0 0 4 0 0 0 0 0 3 0 0 0 0 0 2
++  0 0 0 0 0 5 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0
(At  four weeks after administration)
Inﬁltration of inﬂammatory cells (neutrophils and foamy alveolar macrophages)
±  0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0
+  0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0
Hyperplasia of alveolar epithelium
+ 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0
Five animals were observed in each group.
±, very slight change; +, slight change; ++, mild change.
Fig. 3. Lactate dehydrogenase (LDH) activity in bronchoalveolar lavage ﬂuid at three
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ratio, total protein content, and LDH activity) determined at threeays (A) and at four weeks (B) after intratracheal administration of various forms
f  TiO2. Values are presented as average ± SD. * signiﬁcant difference from control
roup (P < 0.05).
TO-S-3 (Coated). In the animals administered TTO-S-3 (Coated),
nﬁltration of inﬂammatory cells (neutrophils and foamy alveolar
acrophages) or hyperplasia of the alveolar epithelium with thick-
ning of the alveolar wall were observed (Table 2 and Fig. 5). These
ndings are consistent with the results of the BALF examinations,
n which six of the seven test materials induced acute responses,
hereas TTO-S-3 (Coated) induced a subacute response. No toxico-
ogical ﬁndings were observed in any of the other organs examined
or any of the test materials.Fig. 4. Relative lung weight at three days (A) and at four weeks (B) after intratracheal
administration of various forms of TiO2. Values are presented as average ± SD. *
signiﬁcant difference from control group (P < 0.05).
3.4. Associations between physicochemical characteristics of TiO2
and pulmonary inﬂammatory responses in rats
3.4.1. Crystallinity
The associations between the crystallinity of the test materials
and the values of three BALF parameters (differential neutrophildays after administration are shown in Fig. 6. To examine these
associations quantitatively and statistically, the percentage of the
materials in rutile form, as determined by the manufacturer, was
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iig. 5. Representative light micrographs of lung tissue from rats after intratracheal
dministration: (A) Control, (B) MT-150AW, (C) TTO-S-3, (D) TTO-S-3 (Coated), (E) M
TO-S-3, (I) TTO-S-3 (Coated), (J) MP-100.
sed as an index of crystallinity (Table 1). For example, the per-
entage of materials in the rutile form for AMT-100 was  0%, that of
T-150AW was 100%, and that of P25 was 20%. The BALF parame-
er values for the predominantly rutile materials varied greatly, and
o clear trends were observed between the percentage of material
n the rutile form and any of the BALF parameter values. Similarly,
here were also no clear associations between the percentage of
aterial in the rutile form and the values of the BALF parameters
t four weeks after administration (data not shown). Therefore, it
s unlikely that the crystallinity of the test materials was associatedistration of 6 mg/kg of the indicated form of TiO2. At three days after intratracheal
0. At four weeks after intratracheal administration: (F) Control, (G) MT-150AW, (H)
with the acute pulmonary inﬂammatory responses observed in the
rats.
3.4.2. Shape
The associations between the shape of the test materials and
the values of the three BALF parameters determined at three days
after administration are shown in Fig. 7. To examine these associa-
tions quantitatively and statistically, the shape of each test material
was expressed as its aspect ratio (i.e., long axis/short axis). No clear
associations were found between aspect ratio and inﬂammatory
response at three days (Fig. 7) or at four weeks after administration
496 N. Hashizume et al. / Toxicology Reports 3 (2016) 490–500
Fig. 6. Associations between crystallinity (percentage of TiO2 in rutile form) and bronchoalveolar lavage ﬂuid parameter values at three days after intratracheal administration
of  indicated form of TiO2. (A) Differential neutrophil ratio, (B) Total protein content, (C) Lactate dehydrogenase (LDH). Values are presented as the average of the difference
between the value for the 2-mg/kg group and that of the control group. Percentage of TiO2 in rutile form: AMT-100, 0%; MT-150AW, 100%; TTO-S-3, 100%; TTO-S-3 (Coated),
100%; P25, 20%; MP-100, 100%; FTL-100, 100%.
Fig. 7. Associations between aspect ratio and bronchoalveolar lavage ﬂuid parameter values three days after intratracheal administration of various forms of TiO2. (A)
Differential neutrophil ratio, (B) Total protein content, (C) Lactate dehydrogenase (LDH). Values are presented as the average of the difference between the value for the
2-mg/kg group and that of the control group. Aspect ratios: AMT-100, 1.00; MT-150AW, 3.79; TTO-S-3, 5.00; TTO-S-3 (Coated), 5.00; P25, 1.00; MP-100, 1.00; FTL-100, 12.9.
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f the test materials (data not shown). Therefore, it is unlikely that
article shape was associated with the acute pulmonary inﬂamma-
ory responses observed in the rats.
.4.3. Particle size
The associations between the particle size of the test materi-
ls and the values of the three BALF parameters determined at
hree days after administration are shown in Fig. 8. The data for
TL-100 were not plotted because the particle size measured by
eans of dynamic light scattering would have given little effective
nformation due to the material’s large aspect ratio. In Fig. 8, linear
elationships are presented between the logarithm of particle size
nd BALF parameter value. Strong correlations were observed when
he data for TTO-S-3 (Coated) were excluded from the regression
nalysis expressed by using Eqs. (1)–(6):
Differential neutrophil ratio = −65.3 × log (volume average)
+176, r2 = 0.935 (1)
Total protein content = −4.25 × log(volume average)
+11.1, r2 = 0.896 (2)
DH = −36.3 × log(volume average) + 95.1, r2 = 0.792 (3)
Differential neutrophil ratio = −60.0 × log(number average)
+150, r2 = 0.700 (4)
Total protein content = −3.89 × log(number average)
+9.31, r2 = 0.665 (5)
DH = −30.8 × log(number average) + 75.7, r2 = 0.506 (6)
The correlations between BALF parameter value and logarithm
f particle size at three days after administration were strong for all
hree BALF parameters examined, that is, the r2 values for volume
verage diameter were high, and the correlations were statistically
igniﬁcant (P < 0.05). No clear associations between BALF param-
ter value and particle size were observed at four weeks after
dministration (data not shown). Therefore, it is likely that particle
ize, especially volume average diameter, was associated with the
cute—but not the subacute—pulmonary inﬂammatory response
bserved in the rats.
.4.4. Surface coating
In the plots of BALF parameter value versus particle size at
hree days after administration, the plot of TTO-S-3 (Coated)
as located separate from the plots for the other test materials
Fig. 8A–F). Furthermore, the results of the BALF examinations and
istopathological examinations at four weeks after administration
howed that TTO-S-3 (Coated) continued to induce an inﬂamma-
ory response whereas the other test materials did not (Figs. 1–5).
herefore, it is likely that the Al(OH)3 coating the surface of the par-
icles in TTO-S-3 (Coated) had a marked effect on the pulmonary
nﬂammatory response in rats.
.4.5. Categorization of seven TiO2
Using the present results, we categorized the seven TiO2 into
wo groups: a group containing TiO2 with no surface coating (i.e.,
MT-100, MT-150AW, TTO-S-3, P25, MP-100, and FTL-100) and
 group containing the TiO2 with surface coating (i.e., TTO-S-3Reports 3 (2016) 490–500 497
[Coated]). The dose–response curves for the BALF parameters (dif-
ferential neutrophil ratio, total protein content, and LDH activity)
at three days after administration are shown in Fig. 9. When the
administration doses were expressed as mass (mg/kg), the curves
for the BALF parameter values varied greatly (Fig. 9A–C); how-
ever, when the administration doses of each test material were
normalized by particle size (e.g., volume average), that is, by divid-
ing the mass administration dose (mg/kg) by the particle size (nm)
(Fig. 9D–F), the curves for the BALF parameters after administration
of the TiO2 from the ﬁrst group of materials (i.e., the materials with
no surface coating) all ﬁtted the same sigmoidal dose–response
curve (r2 = 0.957 [differential neutrophil ratio], 0.850 [total pro-
tein content], 0.906 [LDH]). This suggests that for the ﬁrst group
of TiO2, the non-coated TiO2, the acute pulmonary inﬂammatory
response (at three days after intratracheal administration) is equiv-
alent when the particle size is the same, regardless of crystallinity
or shape.
4. Discussion
In the present study, all seven TiO2 induced acute pulmonary
inﬂammatory responses at three days after intratracheal admin-
istration in rats, which included increases in the differential
neutrophil ratio, total protein content, and LDH activity in BALF;
inﬁltration of inﬂammatory cells in the lung; and the develop-
ment of hyperplasia of the alveolar epithelium. For six of the seven
test materials, these inﬂammatory responses had recovered at four
weeks after administration to levels comparable to those in the
control groups, which is consistent with the results of a previous
study Nöel et al. [21]. However, rats administered TTO-S-3 (Coated)
continued to exhibit inﬂammatory responses at four weeks after
administration, indicating that this TiO2 also induced subacute pul-
monary toxicity.
The relationships between the physicochemical characteristics
of the TiO2 and the results of the BALF examination showed that
smaller TiO2 particles induced a greater acute pulmonary inﬂam-
matory response than did larger TiO2 particles, irrespective of
particle crystallinity or shape (Fig. 8A–8F). Consistent with this
result, the frequencies and grades of the histopathological ﬁndings
(inﬁltration of inﬂammatory cells and hyperplasia of the alveolar
epithelium) at three days after administration of the test materials
were also greater for the smaller TiO2 particles than for the larger
TiO2 particles (Table 2 and Fig. 5). Several previous studies have
shown that smaller TiO2 particles induce a greater acute inﬂam-
matory response than do larger TiO2 particles after intratracheal
administration [8,9,11]. However, Warheit et al. [12] evaluated
the acute lung toxicity in rats after intratracheal administration
of three TiO2 with different particle sizes (primary particle size:
approx. 300 nm [particles], 200 nm × 35 nm [rods], and approx.
10 nm [dots]) and showed that there were no differences in the
acute inﬂammatory response and cell injury induced by these three
materials. A robust understanding of the effect of TiO2 particle size
on acute pulmonary toxicity in rats is yet to be obtained; however,
in the present study, we  characterized and tested seven forms of
TiO2 in the same laboratory under identical test conditions, and our
results suggest that particle size, especially volume average diam-
eter, may  be associated with the acute pulmonary inﬂammatory
response to intratracheal administration of TiO2 in rats.
Our results also showed that the surface coating of TiO2 parti-
cles might have a marked effect on the pulmonary inﬂammatory
response to intratracheal administration of TiO2 in rats. Sev-
eral previous studies have shown that surface treatment affects
the pulmonary toxicity of TiO2 in rats. For example, Oberdörster
[15] showed that silane-coated TiO2 induces a much lower pul-
monary inﬂammatory response compared with untreated TiO2,
498 N. Hashizume et al. / Toxicology Reports 3 (2016) 490–500
Fig. 8. Associations between particle size (nm) and bronchoalveolar lavage ﬂuid parameter values three days after intratracheal administration of various forms of TiO2.
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re  presented as the average of the difference between the value for the 2-mg/kg g
nd Höhr et al. [14] showed that hydrophobic surface treatment
f TiO2 (achieved through methylation) reduces total cell num-
ers and induces less inﬂux of neutrophils into BALF compared
ith untreated TiO2. Similarly, Warheit et al. [16] showed that TiO2
urface-treated with alumina (Al2O3) and amorphous silica (SiO2)
82% TiO2 + 7% Al2O3 + 11% SiO2) induces mild adverse pulmonary
ffects when compared with the effects induced by untreated TiO2.
ogether with these previous results, the present results indicate
hat altering the surface structure of TiO2 particles affects the rat
ulmonary inﬂammatory response to those particles. Furthermore,
he present results also show that the type of pulmonary inﬂam-
atory response may  be related to the coating material used. That
s, in the present study, TTO-S-3 (Coated), which is surface-coatedactate dehydrogenase (LDH). Number average diameter: (D) Differential neutrophil
 ﬁve test materials (excluding the data for TTO-S-3 (Coated) and FTL-100). Values
nd that of the control group.
with Al(OH)3, induced both an acute and a subacute pulmonary
inﬂammatory response, whereas uncoated TTO-S-3 induced only
an acute pulmonary inﬂammatory response. Further studies are
needed to determine the relationships between surface treatments
and pulmonary inﬂammatory response.
It is known that nanomaterial-induced pulmonary inﬂamma-
tion depends largely on the extent of deposition and clearance
of the material in the lungs [4,22]. Our group previously exam-
ined the pulmonary clearance kinetics of TiO2 in rats by using
the same seven test materials assessed in the present study and
reported that the pulmonary clearance rate constant of TTO-S-3
(Coated) (0.00018–0.011/day) was much lower than those for the
other six uncoated TiO2 (0.0073–0.020/day) [18]. Therefore, slower
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Fig. 9. Dose—response curves for bronchoalveolar lavage ﬂuid parameters three days after intratracheal administration of various forms of TiO2. Administration doses
e ent, (C
( d lines
t roup a
c
i
(
t
c
p
i
(
p
lxpressed as mass (mg/kg): (A) Differential neutrophil ratio, (B) Total protein cont
mg/kg/nm): (D) Differential neutrophil ratio, (E) Total protein content, (F) LDH. Soli
he  data for TTO-S-3 (Coated) and FTL-100). Values were taken from the 2-mg/kg g
learance from the lung may  account for the subacute pulmonary
nﬂammatory response observed after administration of TTO-S-3
Coated) in the present study, although further studies are required
o elucidate the detailed toxicological mechanism.
Together, the present results allow the following three con-
lusions to be drawn regarding the relationship between the
hysicochemical characteristics of nano-TiO2 and the pulmonary
nﬂammatory response after intratracheal administration in rats:
1) crystallinity and shape are unlikely to be associated with acute
ulmonary inﬂammatory responses to TiO2; (2) particle size is
ikely associated with the acute pulmonary inﬂammatory response) Lactate dehydrogenase (LDH). Administration doses normalized by particle size
 are the sigmoidal dose—response curve derived from ﬁve test materials (excluding
nd are presented as average ± SD.
to TiO2; and (3) surface coating has the potential to alter the pul-
monary inﬂammatory response to TiO2.
We next categorized the seven TiO2 into two  groups: a group
containing the six TiO2 with no surface coating (i.e., AMT-100,
MT-150AW, TTO-S-3, P25, MP-100, and FTL-100) and a group con-
taining the one TiO2 with a surface coating (i.e., TTO-S-3 [Coated]).
Intratracheal administration to rats of the TiO2 from the ﬁrst group
of materials induced acute pulmonary inﬂammatory responses, and
within this group, the acute pulmonary inﬂammatory response
(at three days after intratracheal administration) was equivalent
when the particle size was  the same, regardless of crystallinity or
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hape. Therefore, the acute pulmonary inﬂammatory responses in
his group may  be predicted by using the correlation between the
article size of and inﬂammatory responses induced by character-
zed forms of TiO2. In contrast, intratracheal administration to rats
f the TiO2 from the second group (i.e., TTO-S-3 [Coated]) induced a
ore severe, subacute pulmonary inﬂammatory response. The pul-
onary toxicity of coated TiO2 needs to be further evaluated since
he alteration of the pulmonary inﬂammatory response by surface
reatment may  depend on the coating material used.
In summary, the present study provides a possible means of pre-
icting the pulmonary risk of new nano-TiO2 by using the known
ssociations between the physicochemical characteristics and pul-
onary toxicity of characterized forms of TiO2. Additional studies
sing TiO2 with different surface treatments, and examination of
he toxicological mechanisms behind the alteration of the pul-
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onstructing a robust rationale for predicting the pulmonary toxi-
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